1 |
BCL2
| 43件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, Platinum drug resistance 💬, NF-kappa B signaling pathway 💬, HIF-1 signaling pathway 💬, Sphingolipid signaling pathway 💬, p53 signaling pathway 💬, Autophagy - animal 💬, Protein processing in endoplasmic reticulum 💬, PI3K-Akt signaling pathway 💬, Apoptosis 💬, Apoptosis - multiple species 💬, Necroptosis 💬, Adrenergic signaling in cardiomyocytes 💬, Hedgehog signaling pathway 💬, Focal adhesion 💬, NOD-like receptor signaling pathway 💬, JAK-STAT signaling pathway 💬, Neurotrophin signaling pathway 💬, Cholinergic synapse 💬, Estrogen signaling pathway 💬, Parathyroid hormone synthesis, secretion and action 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Amyotrophic lateral sclerosis 💬, Pathways of neurodegeneration - multiple diseases 💬, Shigellosis 💬, Salmonella infection 💬, Toxoplasmosis 💬, Tuberculosis 💬, Hepatitis B 💬, Measles 💬, Herpes simplex virus 1 infection 💬, Epstein-Barr virus infection 💬, Human immunodeficiency virus 1 infection 💬, Pathways in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Colorectal cancer 💬, Prostate cancer 💬, Small cell lung cancer 💬, Gastric cancer 💬, Lipid and atherosclerosis 💬, Fluid shear stress and atherosclerosis 💬 | D10679
D10679
|
Venetoclax
| 1件: 28 28 |
2 |
BMPR2
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, TGF-beta signaling pathway 💬, Axon guidance 💬, Hippo signaling pathway 💬, Signaling pathways regulating pluripotency of stem cells 💬, MicroRNAs in cancer 💬, Fluid shear stress and atherosclerosis 💬 | D03779
D03779
|
Dibotermin alfa
| 1件: 34 34 |
3 |
BRAF
| 44件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Chemokine signaling pathway 💬, FoxO signaling pathway 💬, mTOR signaling pathway 💬, Vascular smooth muscle contraction 💬, Focal adhesion 💬, Natural killer cell mediated cytotoxicity 💬, Long-term potentiation 💬, Neurotrophin signaling pathway 💬, Serotonergic synapse 💬, Long-term depression 💬, Regulation of actin cytoskeleton 💬, Insulin signaling pathway 💬, Progesterone-mediated oocyte maturation 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Alcoholism 💬, Hepatitis C 💬, Hepatitis B 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Renal cell carcinoma 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Thyroid cancer 💬, Melanoma 💬, Bladder cancer 💬, Chronic myeloid leukemia 💬, Acute myeloid leukemia 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬 | D06272
D06272
|
Sorafenib
| 2件: 34 34, 86 |
4 |
BRAF
| 44件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Chemokine signaling pathway 💬, FoxO signaling pathway 💬, mTOR signaling pathway 💬, Vascular smooth muscle contraction 💬, Focal adhesion 💬, Natural killer cell mediated cytotoxicity 💬, Long-term potentiation 💬, Neurotrophin signaling pathway 💬, Serotonergic synapse 💬, Long-term depression 💬, Regulation of actin cytoskeleton 💬, Insulin signaling pathway 💬, Progesterone-mediated oocyte maturation 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Alcoholism 💬, Hepatitis C 💬, Hepatitis B 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Renal cell carcinoma 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Thyroid cancer 💬, Melanoma 💬, Bladder cancer 💬, Chronic myeloid leukemia 💬, Acute myeloid leukemia 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬 | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
5 |
BRAF
| 44件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Chemokine signaling pathway 💬, FoxO signaling pathway 💬, mTOR signaling pathway 💬, Vascular smooth muscle contraction 💬, Focal adhesion 💬, Natural killer cell mediated cytotoxicity 💬, Long-term potentiation 💬, Neurotrophin signaling pathway 💬, Serotonergic synapse 💬, Long-term depression 💬, Regulation of actin cytoskeleton 💬, Insulin signaling pathway 💬, Progesterone-mediated oocyte maturation 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Alcoholism 💬, Hepatitis C 💬, Hepatitis B 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Renal cell carcinoma 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Thyroid cancer 💬, Melanoma 💬, Bladder cancer 💬, Chronic myeloid leukemia 💬, Acute myeloid leukemia 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬 | D10064
D10064
|
Dabrafenib
| 1件: 34 34 |
6 |
BTK
| 7件: NF-kappa B signaling pathway NF-kappa B signaling pathway 💬, Osteoclast differentiation 💬, Platelet activation 💬, B cell receptor signaling pathway 💬, Fc epsilon RI signaling pathway 💬, Epstein-Barr virus infection 💬, Primary immunodeficiency 💬 | D10223
D10223
|
Ibrutinib
| 3件: 28 28, 60, 61 |
7 |
BTK
| 7件: NF-kappa B signaling pathway NF-kappa B signaling pathway 💬, Osteoclast differentiation 💬, Platelet activation 💬, B cell receptor signaling pathway 💬, Fc epsilon RI signaling pathway 💬, Epstein-Barr virus infection 💬, Primary immunodeficiency 💬 | D10893
D10893
|
Acalabrutinib
| 2件: 46 46, 61 |
8 |
BTK
| 7件: NF-kappa B signaling pathway NF-kappa B signaling pathway 💬, Osteoclast differentiation 💬, Platelet activation 💬, B cell receptor signaling pathway 💬, Fc epsilon RI signaling pathway 💬, Epstein-Barr virus infection 💬, Primary immunodeficiency 💬 | D11422
D11422
|
Zanubrutinib
| 2件: 300 300, 331 |
9 |
BTK
| 7件: NF-kappa B signaling pathway NF-kappa B signaling pathway 💬, Osteoclast differentiation 💬, Platelet activation 💬, B cell receptor signaling pathway 💬, Fc epsilon RI signaling pathway 💬, Epstein-Barr virus infection 💬, Primary immunodeficiency 💬 | D11457
D11457
|
Fenebrutinib
| 1件: 13 13 |
10 |
BTK
| 7件: NF-kappa B signaling pathway NF-kappa B signaling pathway 💬, Osteoclast differentiation 💬, Platelet activation 💬, B cell receptor signaling pathway 💬, Fc epsilon RI signaling pathway 💬, Epstein-Barr virus infection 💬, Primary immunodeficiency 💬 | D11478
D11478
|
Branebrutinib
| 3件: 46 46, 49, 53 |
11 |
BTK
| 7件: NF-kappa B signaling pathway NF-kappa B signaling pathway 💬, Osteoclast differentiation 💬, Platelet activation 💬, B cell receptor signaling pathway 💬, Fc epsilon RI signaling pathway 💬, Epstein-Barr virus infection 💬, Primary immunodeficiency 💬 | D12160
D12160
|
Orelabrutinib
| 3件: 13 13, 61, 63 |